Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.
about
Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapyLipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and HypoxiaAutotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasisLipid Signaling in Tumorigenesis.The Marine-Derived Fungus Clonostachys rosea, Source of a Rare Conjugated 4-Me-6E,8E-hexadecadienoic Acid Reducing Viability of MCF-7 Breast Cancer Cells and Gene Expression of Lipogenic EnzymesLysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer CellsThe potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathwaysAberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer.Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.Mammalian SWI/SNF Enzymes and the Epigenetics of Tumor Cell Metabolic Reprogramming.MUC1: a novel metabolic master regulator.Hepatocyte autotaxin expression promotes liver fibrosis and cancer.The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferationAberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.Discrimination of normal and malignant mouse ovarian surface epithelial cells in vitro using Raman microspectroscopy
P2860
Q27015257-3F577A31-09A8-4853-A73B-BD3FB645F870Q28078259-02F3C5AE-EEBF-4334-B76C-F26CDCBE2B3CQ34980426-B031B7B4-0CC7-4DB8-8020-D114223B638AQ35136532-6E575E18-4BF3-45F3-99E4-039883A61C6CQ36018025-16CC3F30-8ED9-49DA-8AE2-218E3BBED1F7Q36177654-7F3BB8F6-8FA6-4D2F-839D-DF797BDE07AFQ36355817-F7EAC05D-4F6C-4C2F-A74F-50AA508153E2Q36820509-3E087056-9DBC-43F8-ADA4-F3AAECF7A6FBQ37196532-23DFEC42-1C5B-4C52-A2C1-C38172268E65Q37736010-BCDE8197-8BBB-4F0A-A379-6CE84E6B21DAQ38177983-B1EA3837-B100-4B69-AF72-06AAF29CF69BQ40422363-1C2B61B3-A4C8-4855-A798-88A557E7C5E0Q42008283-FF311BE8-F81D-444C-849A-41A37874C3C6Q47710637-78165A6C-7409-4556-8B6C-1BFF542A249CQ57699553-A03B73B9-D8D9-459B-B30D-634A8B9DD4B9
P2860
Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Lysophosphatidic acid activate ...... hesis in ovarian cancer cells.
@ast
Lysophosphatidic acid activate ...... hesis in ovarian cancer cells.
@en
type
label
Lysophosphatidic acid activate ...... hesis in ovarian cancer cells.
@ast
Lysophosphatidic acid activate ...... hesis in ovarian cancer cells.
@en
prefLabel
Lysophosphatidic acid activate ...... hesis in ovarian cancer cells.
@ast
Lysophosphatidic acid activate ...... hesis in ovarian cancer cells.
@en
P2093
P2860
P356
P1476
Lysophosphatidic acid activate ...... hesis in ovarian cancer cells.
@en
P2093
Abir Mukherjee
Suzanne Barbour
Xianjun Fang
P2860
P304
24990-25000
P356
10.1074/JBC.M112.340083
P407
P577
2012-06-03T00:00:00Z